566 related articles for article (PubMed ID: 23046820)
1. In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome.
Wang JT; Palme CE; Wang AY; Morgan GJ; Gebski V; Veness MJ
J Laryngol Otol; 2013 Jan; 127 Suppl 1():S2-7. PubMed ID: 23046820
[TBL] [Abstract][Full Text] [Related]
2. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.
Veness MJ; Morgan GJ; Palme CE; Gebski V
Laryngoscope; 2005 May; 115(5):870-5. PubMed ID: 15867656
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center.
Schmidt C; Martin JM; Khoo E; Plank A; Grigg R
Head Neck; 2015 Dec; 37(12):1808-15. PubMed ID: 24995842
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy.
Veness MJ; Palme CE; Smith M; Cakir B; Morgan GJ; Kalnins I
Laryngoscope; 2003 Oct; 113(10):1827-33. PubMed ID: 14520114
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic selective neck dissection: a 25-year review.
Muzaffar K
Laryngoscope; 2003 Sep; 113(9):1460-5. PubMed ID: 12972914
[TBL] [Abstract][Full Text] [Related]
6. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
8. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
[TBL] [Abstract][Full Text] [Related]
9. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
[TBL] [Abstract][Full Text] [Related]
10. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy.
Wang JT; Palme CE; Morgan GJ; Gebski V; Wang AY; Veness MJ
Head Neck; 2012 Nov; 34(11):1524-8. PubMed ID: 22109745
[TBL] [Abstract][Full Text] [Related]
11. Regional control of head and neck melanoma with selective neck dissection.
Geltzeiler M; Monroe M; Givi B; Vetto J; Andersen P; Gross N
JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):1014-8. PubMed ID: 25275362
[TBL] [Abstract][Full Text] [Related]
12. Selective neck dissection in node-positive squamous cell carcinoma of the head and neck.
Givi B; Linkov G; Ganly I; Patel SG; Wong RJ; Singh B; Boyle JO; Shaha AR; Shah JP; Kraus DH
Otolaryngol Head Neck Surg; 2012 Oct; 147(4):707-15. PubMed ID: 22517013
[TBL] [Abstract][Full Text] [Related]
13. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Safety of Selective Neck Dissection in Lymph Node-Positive Squamous Cell Carcinoma of the Head and Neck.
Polat M; Celenk F; Baysal E; Durucu C; Kul S; Mumbuc S; Kanlikama M
J Craniofac Surg; 2015 Jul; 26(5):e380-3. PubMed ID: 26102544
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach.
Patel RS; Clark J; Wyten R; Gao K; O'Brien CJ
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1282-7. PubMed ID: 18086973
[TBL] [Abstract][Full Text] [Related]
16. Metastatic head and neck cutaneous squamous cell carcinoma: defining a low-risk patient.
Ebrahimi A; Clark JR; Lorincz BB; Milross CG; Veness MJ
Head Neck; 2012 Mar; 34(3):365-70. PubMed ID: 21472887
[TBL] [Abstract][Full Text] [Related]
17. Management of Parotid Metastatic Cutaneous Squamous Cell Carcinoma: Regional Recurrence Rates and Survival.
Hirshoren N; Ruskin O; McDowell LJ; Magarey M; Kleid S; Dixon BJ
Otolaryngol Head Neck Surg; 2018 Aug; 159(2):293-299. PubMed ID: 29533706
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
[TBL] [Abstract][Full Text] [Related]
19. Results in suprahyoid, modified radical, and standard radical neck dissections for metastatic squamous cell carcinoma: recurrence and survival.
Chu W; Strawitz JG
Am J Surg; 1978 Oct; 136(4):512-5. PubMed ID: 707733
[TBL] [Abstract][Full Text] [Related]
20. Metastatic cutaneous squamous cell carcinoma to parotid nodes: the role of bolus with adjuvant radiotherapy.
Pramana A; Browne L; Graham PH
J Med Imaging Radiat Oncol; 2012 Feb; 56(1):100-8. PubMed ID: 22339753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
